141 related articles for article (PubMed ID: 2804902)
1. Renal cell carcinoma. A clinicopathologic and DNA flow cytometric analysis of 103 cases.
Grignon DJ; Ayala AG; el-Naggar A; Wishnow KI; Ro JY; Swanson DA; McLemore D; Giacco GG; Guinee VF
Cancer; 1989 Nov; 64(10):2133-40. PubMed ID: 2804902
[TBL] [Abstract][Full Text] [Related]
2. DNA flow cytometry as a predictor of outcome of stage I renal cell carcinoma.
Grignon DJ; el-Naggar A; Green LK; Ayala AG; Ro JY; Swanson DA; Troncoso P; McLemore D; Giacco GG; Guinee VF
Cancer; 1989 Mar; 63(6):1161-5. PubMed ID: 2917319
[TBL] [Abstract][Full Text] [Related]
3. DNA ploidy pattern in papillary renal cell carcinoma. Correlation with clinicopathological parameters and survival.
del Vecchio MT; Lazzi S; Bruni A; Mangiavacchi P; Cevenini G; Luzi P
Pathol Res Pract; 1998; 194(5):325-33. PubMed ID: 9651945
[TBL] [Abstract][Full Text] [Related]
4. Papillary renal cell carcinoma: clinical implication of DNA content analysis.
el-Naggar AK; Ro JY; Ensign LG
Hum Pathol; 1993 Mar; 24(3):316-21. PubMed ID: 8454276
[TBL] [Abstract][Full Text] [Related]
5. DNA ploidy is a valuable predictor for prognosis of patients with resected renal cell carcinoma.
Abou-Rebyeh H; Borgmann V; Nagel R; Al-Abadi H
Cancer; 2001 Nov; 92(9):2280-5. PubMed ID: 11745282
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of clinicopathologic and deoxyribonucleic acid flow cytometric variables in non-metastatic renal cell carcinoma in the modern era.
Clark PE; Veys JA; Eskridge MR; Woodruff RD; Hall MC
Urol Oncol; 2005; 23(5):328-32. PubMed ID: 16144666
[TBL] [Abstract][Full Text] [Related]
7. Flow cytometric assessment of deoxyribonucleic acid content in renal adenocarcinoma: does ploidy status enhance prognostic stratification over stage alone?
Currin SM; Lee SE; Walther PJ
J Urol; 1990 Mar; 143(3):458-63. PubMed ID: 2304153
[TBL] [Abstract][Full Text] [Related]
8. Flow cytometric deoxyribonucleic acid analysis in stage I renal cell carcinoma.
Ljungberg B; Larsson P; Stenling R; Roos G
J Urol; 1991 Sep; 146(3):697-9. PubMed ID: 1875475
[TBL] [Abstract][Full Text] [Related]
9. Biological and clinical implication of cellular DNA content in renal cell carcinomas.
Di Silverio F; Gallucci M; Flammia GP; De Vico A; Caponera M; Eleuteri P; Forte D; Cavallo D; De Vita R
Eur Urol; 1992; 21 Suppl 1():43-7. PubMed ID: 1425835
[TBL] [Abstract][Full Text] [Related]
10. Expression of proliferating cell nuclear antigen and deoxyribonucleic acid value in renal cell carcinoma: correlation with different histopathological parameters and patient survival.
Shameem IA; Shimabukuro T; Wada T; Kurisu H; Naito K
Eur Urol; 1996; 29(1):78-84. PubMed ID: 8821696
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of ploidy, MIB-1 proliferation marker, and p53 in renal cell carcinoma.
Kramer BA; Gao X; Davis M; Hall M; Holzbeierlein J; Tawfik O
J Am Coll Surg; 2005 Oct; 201(4):565-70. PubMed ID: 16183495
[TBL] [Abstract][Full Text] [Related]
12. Independent value of tumor size and DNA ploidy for the prediction of disease progression in patients with organ-confined renal cell carcinoma.
Di Silverio F; Casale P; Colella D; Andrea L; Seccareccia F; Sciarra A
Cancer; 2000 Feb; 88(4):835-43. PubMed ID: 10679653
[TBL] [Abstract][Full Text] [Related]
13. The prognostic value of DNA ploidy in small renal cell carcinoma.
Shalev M; Gdor Y; Leventis A; Radnay J; Shapiro H; Bernheim J; Nissenkorn I
Pathol Res Pract; 2001; 197(1):7-12. PubMed ID: 11209819
[TBL] [Abstract][Full Text] [Related]
14. Prognostic evaluation of DNA flow cytometry and histo-morphological criteria in renal cell carcinoma.
Eskelinen M; Lipponen P; Nordling S
Anticancer Res; 1995; 15(5B):2279-83. PubMed ID: 8572637
[TBL] [Abstract][Full Text] [Related]
15. Value of deoxyribonucleic acid ploidy and nuclear morphometry for prediction of disease progression in renal cell carcinoma.
Ruiz-Cerdá JL; Hernández M; Gomis F; Vera CD; Kimler BF; O'Connor JE; Jiménez-Cruz F
J Urol; 1996 Feb; 155(2):459-65. PubMed ID: 8558635
[TBL] [Abstract][Full Text] [Related]
16. Ploidy and prognosis in renal carcinoma.
Lanigan D; McLean PA; Murphy DM; Donovan MG; Curran B; Leader M
Br J Urol; 1993 Jan; 71(1):21-4. PubMed ID: 8435731
[TBL] [Abstract][Full Text] [Related]
17. Image analysis in the determination of ploidy and prognosis in renal cell carcinoma.
Lanigan DJ; McLean PA; Murphy DM; Donovan MG; Leader M
Eur Urol; 1992; 22(3):228-34. PubMed ID: 1468480
[TBL] [Abstract][Full Text] [Related]
18. Primary sarcomas of the kidney. A clinicopathologic and DNA flow cytometric study of 17 cases.
Grignon DJ; Ayala AG; Ro JY; el-Naggar A; Papadopoulos NJ
Cancer; 1990 Apr; 65(7):1611-8. PubMed ID: 2155701
[TBL] [Abstract][Full Text] [Related]
19. [Usefulness of DNA ploidy, AgNORs, PCNA and c-erbB-2 as predictors of prognosis in patients with renal cell carcinoma].
Tamaki M; Maeda S; Deguchi T; Kawada Y
Hinyokika Kiyo; 1997 Oct; 43(10):697-702. PubMed ID: 9395903
[TBL] [Abstract][Full Text] [Related]
20. Flow cytometric analysis of nuclear DNA content of renal cell carcinoma correlated with histologic and clinical features.
Nakano E; Kondoh M; Okatani K; Seguchi T; Sugao H
Cancer; 1993 Aug; 72(4):1319-23. PubMed ID: 8339220
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]